-
661
Impact of metformin on statin‐associated myopathy risks in dyslipidemia patients
Published 2023-08-01Subjects: “…drug interactions…”
Get full text
Article -
662
Clinical and demographic characteristics, and problems related to medication in patients with 50 or more years with recent diagnosis of HIV in Medellín, Colombia
Published 2023-04-01Subjects: “…drug interactions…”
Get full text
Article -
663
Synergism between rocuronium and cisatracurium: comparison of the Minto and Greco interaction models
Published 2016-08-01Subjects: Get full text
Article -
664
Polypharmacy in Older Adults with Alzheimer’s Disease
Published 2022-10-01Subjects: Get full text
Article -
665
-
666
Potential Drug–Drug Interactions Among Hospitalised Elderly Patients in Northern Sri Lanka, A Lower Middle-Income Country: A Retrospective Analysis
Published 2022-11-01“…Abstract Background and Objectives Elderly individuals are more vulnerable to potential drug–drug interactions (pDDIs) as age-related physiological changes, polypharmacy and hospitalisations are known to increase the risk of pDDIs. …”
Get full text
Article -
667
Prevalence of potential drug–drug interactions with disease‐specific treatments in patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension: A registry study
Published 2022-07-01“…All prescribed drugs, on an individual level, dispensed 2016–2017 at pharmacies to patients with PAH or CTEPH were obtained from The National Board of Health and Welfare's pharmaceutical registry. Potential drug–drug interactions were investigated using the Drug Interaction tool in the IBM Micromedex® database. …”
Get full text
Article -
668
The Development and Validation of a Novel “Dual Cocktail” Probe for Cytochrome P450s and Transporter Functions to Evaluate Pharmacokinetic Drug-Drug and Herb-Drug Interactions
Published 2020-09-01Subjects: “…pharmacokinetic drug-drug interaction…”
Get full text
Article -
669
Unmanaged Pharmacogenomic and Drug Interaction Risk Associations with Hospital Length of Stay among Medicare Advantage Members with COVID-19: A Retrospective Cohort Study
Published 2021-11-01“…Unmanaged pharmacogenomic and drug interaction risk can lengthen hospitalization and may have influenced the severe health outcomes seen in some COVID-19 patients. …”
Get full text
Article -
670
-
671
-
672
-
673
-
674
-
675
-
676
Physiologically Based Pharmacokinetic (PBPK) Modeling to Predict CYP3A-Mediated Drug Interaction between Saxagliptin and Nicardipine: Bridging Rat-to-Human Extrapolation
Published 2024-02-01Subjects: “…drug–drug interaction…”
Get full text
Article -
677
-
678
-
679
Physiologically-Based Pharmacokinetic Modeling for Drug-Drug Interactions of Procainamide and N-Acetylprocainamide with Cimetidine, an Inhibitor of rOCT2 and rMATE1, in Rats
Published 2019-03-01Subjects: “…physiologically-based pharmacokinetic modeling for drug-drug interactions…”
Get full text
Article -
680
In vitro effect of Withania somnifera, AYUSH-64, and remdesivir on the activity of CYP-450 enzymes: Implications for possible herb−drug interactions in the management of COVID-19
Published 2022-10-01“…The study also implies possible herb−drug interactions as ashwagandha and AYUSH-64 are being used for managing various pathological conditions. …”
Get full text
Article